Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:03:43.723Z.
Calculation as of: 2026-10-06T16:03:43.723Z.
Quote observation: 2026-10-06T15:54:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b407bf9ab9426f7f8731c51b1e955f2cfcbe23f9f3e819a9868889fb687bb4da
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Pasithea Therapeutics Corp.
Market Cap
$15.25M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Operating Cash Flow Yield
N/A
TTM Avg
1.78%
3Y Avg
1.78%
5Y Avg
1.78%
Market Cap
$15.07M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.75M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.44M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.05M
Operating Cash Flow Yield
N/A
TTM Avg
4.27%
3Y Avg
3.48%
5Y Avg
4.26%
Market Cap
$16.49M
Operating Cash Flow Yield
N/A
TTM Avg
2.46%
3Y Avg
5.67%
5Y Avg
4.13%
Market Cap
$13.97M
Operating Cash Flow Yield
3.76%
TTM Avg
3.56%
3Y Avg
3.56%
5Y Avg
3.56%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $15.25M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | 1.78% | 1.78% | 1.78% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.07M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | N/A | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.51M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.05M | N/A | 4.27% | 3.48% | 4.26% |
| Dyadic International, Inc. (DYAI)vs › | $16.49M | N/A | 2.46% | 5.67% | 4.13% |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | 3.76% | 3.56% | 3.56% | 3.56% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.88M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
